Back
 JCDSA  Vol.6 No.1 , March 2016
Clinical Evaluation of Novel Natural Polysaccharides Sacran as a Skincare Material for Atopic Dermatitis Patients
Abstract: Atopic dermatitis is a skin disease characterized by inflammation, pruritus, and chronic or relapsing eczematous lesions. Recently, ampholytic polysaccharide sacran has attracted a particular focus of attention as a novel biomaterial. In the present study, we investigated the effect of sacran solution on atopic dermatitis in the clinical study. Almost all of the average scores for atopic dermatitis symptoms of each patient treated with sacran solutions were improved. In addition, the scores of sleep disorder and itching were also significantly ameliorated by the sacran treatment for 4 weeks, compared with those of initial states. In immatured dermal skin model stimulated with 2,4-dinitrofluorobenzene (DNFB), the sacran treatment markedly down-regulated inflammatory cytokine and chemokine mRNA levels such as MCP-1, TNF-α, IL-1β, and IL-6 mRNAs, compared with that of DNFB alone. Furthermore, a sacran solution significantly suppressed the mRNA expression of TNF-α and COX-2 in RAW264.7 cells, a murine macrophage-like cell line, stimulated with phorbol-12-myristate-13-acetate (PMA). In RBL-2H3 cells, a rat basophilic leukemia cell line, a sacran solution significantly lowered β-hexosaminidase release, indicating the suppression of allergic response. These results suggest that a sacran solution may have the potential to improve atopic dermatitis through the impairment of production of inflammatory cytokine and chemokine mRNA.
Cite this paper: Fukushima, S. , Motoyama, K. , Tanida, Y. , Higashi, T. , Ishitsuka, Y. , Kondo, Y. , Irie, T. , Tanaka, T. , Ihn, H. and Arima, H. (2016) Clinical Evaluation of Novel Natural Polysaccharides Sacran as a Skincare Material for Atopic Dermatitis Patients. Journal of Cosmetics, Dermatological Sciences and Applications, 6, 9-18. doi: 10.4236/jcdsa.2016.61002.
References

[1]   Hengge, U.R., Ruzicka, T., Schwartz, R.A. and Cork, M.J. (2006) Adverse Effects of Topical Glucocorticosteroids. Journal of the American Academy of Dermatology, 54, 1-15.
http://dx.doi.org/10.1016/j.jaad.2005.01.010

[2]   Schoepe, S., Schacke, H., May, E. and Asadullah, K. (2006) Glucocorticoid Therapy-Induced Skin Atrophy. Experimental Dermatology, 15, 406-420.
http://dx.doi.org/10.1111/j.0906-6705.2006.00435.x

[3]   Ananthi, S., Raghavendran, H.R., Sunil, A.G., Gayathri, V., Ramakrishnan, G. and Vasanthi, H.R. (2010) In vitro Antioxidant and in Vivo Anti-Inflammatory Potential of Crude Polysaccharide from Turbinaria ornata (Marine Brown Alga). Food and Chemical Toxicology, 48, 187-192.
http://dx.doi.org/10.1016/j.fct.2009.09.036

[4]   Averbeck, M., Gebhardt, C.A., Voigt, S., Beilharz, S., Anderegg, U., Termeer, C.C., Sleeman, J.P. and Simon, J.C. (2007) Differential Regulation of Hyaluronan Metabolism in the Epidermal and Dermal Compartments of Human Skin by UVB Irradiation. Journal of Investigative Dermatology, 127, 687-697.
http://dx.doi.org/10.1038/sj.jid.5700614

[5]   Yanase, Y., Hiragun, T., Uchida, K., Ishii, K., Oomizu, S., Suzuki, H., Mihara, S., Iwamoto, K., Matsuo, H., Onishi, N., Kameyoshi, Y. and Hide, M. (2009) Peritoneal Injection of Fucoidan Suppresses the Increase of Plasma IgE Induced by OVA-Sensitization. Biochemical and Biophysical Research Communications, 387, 435-439.
http://dx.doi.org/10.1016/j.bbrc.2009.07.031

[6]   Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J. and Zako, M. (1999) Functions of Cell Surface Heparan Sulfate Proteoglycans. Annual Review of Biochemistry, 68, 729-777.
http://dx.doi.org/10.1146/annurev.biochem.68.1.729

[7]   Kawashima, H., Atarashi, K., Hirose, M., Hirose, J., Yamada, S., Sugahara, K. and Miyasaka, M. (2002) Oversulfated Chondroitin/Dermatan Sulfates Containing GlcAb1/IdoAa1-3GalNAc (4,6-O-Disulfate) Interact with L- and P-Selectin and Chemokines. Journal of Biological Chemistry, 277, 12921-12930.
http://dx.doi.org/10.1074/jbc.M200396200

[8]   Taylor, K.R. and Gallo, R.L. (2006) Glycosaminoglycans and Their Proteoglycans: Host-Associated Molecular Patterns for Initiation and Modulation of Inflammation. FASEB Journal, 20, 9-22.
http://dx.doi.org/10.1096/fj.05-4682rev

[9]   Okajima, M.K., Bamba, T., Kaneso, Y., Hirata, K., Fukusaki, E., Kajiyama, S. and Kaneko, T. (2008) Supergiant Ampholytic Sugar Chains with Imbalanced Charge Ratio form Saline Ultra-Absorbent Hydrogels. Macromolecules, 41, 4061-4064.
http://dx.doi.org/10.1021/ma800307w

[10]   Okajima, M.K., Higashi, T., Asakawa, R., Mitsumata, T., Kaneko, D., Kaneko, T., Ogawa, T., Kurata, H. and Isoda, S. (2010) Gelation Behavior by the Lanthanoid Adsorption of the Cyanobacterial Extracellular Polysaccharide. Biomacromolecules, 11, 3172-3177.
http://dx.doi.org/10.1021/bm101012u

[11]   Okajima, M.K., Kaneko, D., Mitsumata, T., Kaneko, T. and Watanabe, J. (2009) Cyanobacteria That Produce Megamolecules with Efficient Self-Orientations. Macromolecules, 42, 3057-3062.
http://dx.doi.org/10.1021/ma802829x

[12]   Okajima, M.K., Miyazato, S. and Kaneko, T. (2009) Cyanobacterial Megamolecule Sacran Efficiently Forms LC Gels with Very Heavy Metal Ions. Langmuir, 25, 8526-8231.
http://dx.doi.org/10.1021/la8036956

[13]   Okajima, M.K., Nakamura, M., Mitsumata, T. and Kaneko, T. (2010) Cyanobacterial Polysaccharide Gels with Efficient Rare-Earth-Metal Sorption. Biomacromolecules, 11, 1773-1778.
http://dx.doi.org/10.1021/bm100231q

[14]   Ngatu, N.R., Okajima, M.K., Yokogawa, M., Hirota, R., Eitoku, M., Muzembo, B.A., Dumavibhat, N., Takaishi, M., Sano, S., Kaneko, T., Tanaka, T., Nakamura, H. and Suganuma, N. (2012) Anti-Inflammatory Effects of Sacran, a Novel Polysaccharide from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene-Induced Allergic Dermatitis in Vivo. Annals of Allergy, Asthma & Immunology, 108, 117-122.
http://dx.doi.org/10.1016/j.anai.2011.10.013

[15]   Okajima, M.K., Ono, M., Kabata, K. and Kaneko, T. (2007) Extraction of Novel Sulfated Polysacchardes from Aphanothece sacrum, and Its Spectroscopic Characterization. Pure and Applied Chemistry, 79, 2039-2046.

[16]   Bircher, A., de Boer, E.M., Agner, T., Wahlberg, J.E. and Serup, J. (1994) Guidelines for Measurement of Cutaneous Blood Flow by Laser Doppler Flowmetry. A Report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis, 30, 65-72.
http://dx.doi.org/10.1111/j.1600-0536.1994.tb00565.x

[17]   Tewtrakul, S. and Subhadhirasakul, S. (2007) Anti-Allergic Activity of Some Selected Plants in the Zingiberaceae Family. Journal of Ethnopharmacology, 109, 535-538.
http://dx.doi.org/10.1016/j.jep.2006.08.010

[18]   Jin, H., He, R., Oyoshi, M. and Geha, R.S. (2009) Animal Models of Atopic Dermatitis. Journal of Investigative Dermatology, 129, 31-40.
http://dx.doi.org/10.1038/jid.2008.106

[19]   Gu, H., Huang, L., Wong, Y.P. and Burd, A. (2010) HA Modulation of Epidermal Morphogenesis in an Organotypic Keratinocyte-Fibroblast Co-Culture Model. Experimental Dermatology, 19, e336-e339.
http://dx.doi.org/10.1111/j.1600-0625.2009.01052.x

[20]   Homey, B., Steinhoff, M., Ruzicka, T. and Leung, D.Y. (2006) Cytokines and Chemokines Orchestrate Atopic Skin Inflammation. Journal of Allergy and Clinical Immunology, 118, 178-189.
http://dx.doi.org/10.1016/j.jaci.2006.03.047

[21]   Yamashita, H., Tasaki, D., Makino, T., Matsuoka, K., Nose, M., Inagaki, N. and Mizukami, H. (2009) The Role of IgE and Repeated Challenge in the Induction of Persistent Increases in Scratching Behavior in a Mouse Model of Allergic Dermatitis. European Journal of Pharmacology, 605, 153-157.
http://dx.doi.org/10.1016/j.ejphar.2009.01.006

[22]   Seldin, D.C., Adelman, S., Austen, K.F., Stevens, R.L., Hein, A., Caulfield, J.P. and Woodbury, R.G. (1985) Homology of the Rat Basophilic Leukemia Cell and the Rat Mucosal Mast Cell. Proceedings of the National Academy of Sciences of the United States of America, 82, 3871-3875.
http://dx.doi.org/10.1073/pnas.82.11.3871

[23]   Kuschert, G.S., Coulin, F., Power, C.A., Proudfoot, A.E., Hubbard, R.E., Hoogewerf, A.J. and Wells, T.N. (1999) Glycosaminoglycans Interact Selectively with Chemokines and Modulate Receptor Binding and Cellular Responses. Biochemistry, 38, 12959-12968.
http://dx.doi.org/10.1021/bi990711d

[24]   Parish, C.R. (2006) The Role of Heparan Sulphate in Inflammation. Nature Reviews Immunology, 6, 633-643.
http://dx.doi.org/10.1038/nri1918

[25]   Park, H.Y., Han, M.H., Park, C., Jin, C.Y., Kim, G.Y., Choi, I.W., Kim, N.D., Nam, T.J., Kwon, T.K. and Choi, Y.H. (2011) Anti-Inflammatory Effects of Fucoidan through Inhibition of NF-KappaB, MAPK and Akt Activation in Lipopolysaccharide-Induced BV2 Microglia Cells. Food and Chemical Toxicology, 49, 1745-1752.
http://dx.doi.org/10.1016/j.fct.2011.04.020

[26]   Volpi, N. (2006) Therapeutic Applications of Glycosaminoglycans. Current Medicinal Chemistry, 13, 1799-1810.
http://dx.doi.org/10.2174/092986706777452470

[27]   Yamada, S. and Sugahara, K. (2008) Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate. Current Drug Discovery Technologies, 5, 289-301.
http://dx.doi.org/10.2174/157016308786733564

[28]   Salmivirta, M., Lidholt, K. and Lindahl, U. (1996) Heparan Sulfate: A Piece of Information. The FASEB Journal, 10, 1270-1279.

 
 
Top